Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative dexmedetomidine dose comparison for postoperative cognitive outcomes after cardiac surgery
TCTR20260921006Phase 3Recruiting
- Sponsor
- N/A
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in post-operative cognitive decline (POCD) (3 arms), sponsored by N/A. Primary endpoint: Incidence of postoperative cognitive dysfunction. Started Mar 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on TCTR20260921006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260921006.